Advertisement
Advertisement

PRME

PRME logo

Prime Medicine, Inc. Common Stock

3.27
USD
Sponsored
-0.03
-0.91%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

3.32

+0.05
+1.65%

Prime Medicine, Inc. Common Stock Profile

About

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Allan Reine

Headquarters

60 First Street
Cambridge, MA 02141, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://primemedicine.com

Auditor

PricewaterhouseCoopers LLP

Share holders

14

Employees

146

Prime Medicine, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

600.37M

Enterprise Value

537.34M

Enterprise Value/EBITDA(ttm)

-2.65

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

136.82

Price to Book(mrq)

5.24

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-4342.44%

Profit Margin(ttm)

-4478.32%

Return on Equity(ttm)

-178.60%

Return on Invested Capital(ttm)

-204.32%

Return on Assets(ttm)

-60.27%

Income Statement

Revenue(ttm)

4.63M

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

4.63M

EBITDA(ttm)3

-202.97M

Net Income Available to Common(ttm)

-201.14M

Diluted EPS(ttm)

-1.35

Share Statistics

Beta (5Y Monthly)

2.65

52-Week Change

157.48%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

180.55M

Dividend Yield

0.00%

Float4

139.49M

% Held by Insiders

22.74%

% Held by Institutions

70.37%

Balance Sheet

Total Cash(mrq)

177.68M

Total Cash Per Share(mrq)

0.98

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.84%

Quick Ratio(mrq)

4.84%

Book Value Per Share(mrq)

0.67

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.09

Free Cash Flow(ytd)

-167.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement